135 more hours on average of operational availability per year. Gain time to treat more patients in your interventional suite.1
91% of Azurion users think the enhanced touch screen module technology increases the ease of use when switching between compatible applications (e.g., X-ray, IVUS, hemo, etc.) during interventions compared to their current system.2, 3
with IVUS guided EVAR procedures.3
Azurion Image Guided Therapy system offers innovations designed to help you work efficiently and consistently. It aids teams in addressing clinical challenges in aortic procedures, while they maintain a single-minded focus on the patient and on managing radiation dose during interventions.
VesselNavigator helps reduce the need for contrast by providing an intuitive and continuous 3D roadmap based on existing CTA and MRA datasets to guide you through vasculature during aortic procedures.
SmartCT Soft Tissue provides CT-like visualization of soft tissue, bone and vascular structures. This X-ray acquisition technique generates CT-like visualization of soft tissue in relation to other structures during procedures – all controlled via the touchscreen at tableside.
Intravascular ultrasound (IVUS) is a catheter-based imaging technology that enhances disease state visibility from the inside out, which aids clinicians in the assessment of presence and extent of disease. IVUS helps clinicians to decide, guide and confirm the right interventional treatment for each patient.
This unique innovation, available to you exclusively from Philips, enables real-time, 3D visualization of devices* inside the body using the wonders of light.
“It is a huge feature that we are using all the time”
Prof. Dr. A. Schanzer, UMass Memorial Medical Center
Worcester, Massachusetts, USA
[1] Data shown is an average, based on the comparison between remotely connected and non-remotely connected systems. Data sample from 2018 for Allura FD and Azurion systems (n=9955).
[2] Results obtained during a Usability Evaluation in the period of May and June 2019.The tests involved 23 clinicians (16 physicians and 7 technologists) from Europe who performed procedures using Azurion 2.1 image guided therapy system in a cardiac workflow and non-cardiac workflow in a simulated interventional lab environment.
[3] Hoshina, et al. A Retrospective Study of Intravascular Ultrasound use in Patients Undergoing Endovascular Aneurysm Repair: Its Usefulness and a Description of the Procedure. Eur J Vasc Endovasc Surg. 2010;40:559-563.
[4] Results from case studies are not predictive of results in other cases. Results in other cases may vary.
[5] The results of the application of dose reduction techniques will vary depending on the clinical task, patient size, anatomical location and clinical practice. The interventional radiologist assisted by a physicist as necessary has to determine the appropriate settings for each specific clinical task.
[6] Results based on total dose area product from a single center prospective historically controlled cohort study on 37 patients (18 for Allura Xper without ClarityIQ and 19 for Allura Xper with ClarityIQ). Procedural performances (fluoroscopy time and contrast medium) of the physician did not significantly differ between the two cohorts.
* The FORS-enabled guidewire as well as compatible endovascular catheters.
Always read the label and follow the directions for use.Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.
Products subject to country availability. Please contact your local sales representative.©2024 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners. Philips reserves the right to change product specifications without prior notification.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.